Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03526081 · ClinicalTrials.gov registry record · NA
Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03526081: Completed NA study, sponsored by University of California, Davis.
NCT03526081 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03526081, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Probe dietary intervention study in healthy young adult males to evaluate the concentration of apigenin derived metabolites in plasma and urine after single acute intakes of different apigenin-containing test materials.
Primary Outcome
Concentration of flavone metabolites in plasma
Interventions
- OTHER Chamomile Tea
- OTHER Parsley based drink
- OTHER Parsley Yogurt
- OTHER Apigenin
- OTHER Parsley-based drink (II)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-01-20 |
| Est. Completion | 2016-07-30 |
| Phase | NA |
What the finished NCT03526081 record still lists
NCT03526081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Chamomile Tea is the first listed.
NCT03526081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03526081 about?
NCT03526081 is a clinical study titled "Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides". Probe dietary intervention study in healthy young adult males to evaluate the concentration of apigenin derived metabolites in plasma and urine after single acute intakes of different apigenin-containing test materials.
What is the current status of trial NCT03526081?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2015-01-20. Estimated completion is 2016-07-30.
What interventions are being tested in trial NCT03526081?
The interventions under investigation include: Chamomile Tea (OTHER), Parsley based drink (OTHER), Parsley Yogurt (OTHER), Apigenin (OTHER), Parsley-based drink (II) (OTHER).
Who is sponsoring clinical trial NCT03526081?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03526081's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI